Extracellular Vesicles in Tumor-adipose Tissue Crosstalk: Key Drivers and Therapeutic Targets in Cancer Cachexia

Overview

Journal Extracell Vesicles Circ Nucl Acids

Date 2024 Dec 19

PMID 39697630

Authors

Catia C Ramos

Jose Pires

Esperanza Gonzalez

Clara Garcia-Vallicrosa

Celso A Reis

Juan M Falcon-Perez

Daniela Freitas

Affiliations

Soon will be listed here.

Abstract

Cancer cachexia is a complex metabolic syndrome characterized by unintentional loss of skeletal muscle and body fat. This syndrome is frequently associated with different types of cancer and negatively affects the prognosis and outcome of these patients. It involves a dynamic interplay between tumor cells and adipose tissue, where tumor-derived extracellular vesicles (EVs) play a crucial role in mediating intercellular communication. Tumor cells release EVs containing bioactive molecules such as hormones (adrenomedullin, PTHrP), pro-inflammatory cytokines (IL-6), and miRNAs (miR-1304-3p, miR-204-5p, miR-155, miR-425-3p, miR-146b-5p, miR-92a-3p), which can trigger lipolysis and induce the browning of white adipocytes contributing to a cancer cachexia phenotype. On the other hand, adipocyte-derived EVs can reprogram the metabolism of tumor cells by transporting fatty acids and enzymes involved in fatty acid oxidation, resulting in tumor growth and progression. These vesicles also carry leptin and key miRNAs (miR-155-5p, miR-10a-3p, miR-30a-3p, miR-32a/b, miR-21), thereby supporting tumor cell proliferation, metastasis formation, and therapy resistance. Understanding the intricate network underlying EV-mediated communication between tumor cells and adipocytes can provide critical insights into the mechanisms driving cancer cachexia. This review consolidates current knowledge on the crosstalk between tumor cells and adipose tissue mediated by EVs and offers valuable insights for future research. It also addresses controversial topics in the field and possible therapeutic approaches to manage cancer cachexia and ultimately improve patient outcomes and quality of life.

References

Di W, Zhang W, Zhu B, Li X, Tang Q, Zhou Y . Colorectal cancer prompted adipose tissue browning and cancer cachexia through transferring exosomal miR-146b-5p. J Cell Physiol. 2020; 236(7):5399-5410. DOI: 10.1002/jcp.30245. View

Coelho M, Oliveira T, Fernandes R . Biochemistry of adipose tissue: an endocrine organ. Arch Med Sci. 2013; 9(2):191-200. PMC: 3648822. DOI: 10.5114/aoms.2013.33181. View

Sohn W, Lee H, Lee S, Lim J, Lee M, Park C . Obesity and the risk of primary liver cancer: A systematic review and meta-analysis. Clin Mol Hepatol. 2020; 27(1):157-174. PMC: 7820201. DOI: 10.3350/cmh.2020.0176. View

Argiles J, Betancourt A, Guardia-Olmos J, Pero-Cebollero M, Lopez-Soriano F, Madeddu C . Validation of the CAchexia SCOre (CASCO). Staging Cancer Patients: The Use of miniCASCO as a Simplified Tool. Front Physiol. 2017; 8:92. PMC: 5313479. DOI: 10.3389/fphys.2017.00092. View

Yi S, Kim H, Oh H, Shin H, Lee J, Park J . Gene expression profiling of chondrogenic differentiation by dexamethasone-conjugated polyethyleneimine with SOX trio genes in stem cells. Stem Cell Res Ther. 2018; 9(1):341. PMC: 6286596. DOI: 10.1186/s13287-018-0998-7. View

Gernapudi R, Yao Y, Zhang Y, Wolfson B, Roy S, Duru N . Targeting exosomes from preadipocytes inhibits preadipocyte to cancer stem cell signaling in early-stage breast cancer. Breast Cancer Res Treat. 2015; 150(3):685-95. PMC: 4385483. DOI: 10.1007/s10549-015-3326-2. View

Argiles J, Lopez-Soriano F, Busquets S . Mediators of cachexia in cancer patients. Nutrition. 2019; 66:11-15. DOI: 10.1016/j.nut.2019.03.012. View

Neshan M, Tsilimigras D, Han X, Zhu H, Pawlik T . Molecular Mechanisms of Cachexia: A Review. Cells. 2024; 13(3. PMC: 10854699. DOI: 10.3390/cells13030252. View

Stewart G, Skipworth R, Fearon K . Cancer cachexia and fatigue. Clin Med (Lond). 2006; 6(2):140-3. PMC: 4953193. DOI: 10.7861/clinmedicine.6-2-140. View

10.

Jia Z, Zhu H, Sun H, Hua Y, Zhang G, Jiang J . Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt/β-Catenin Signaling. Cancer Manag Res. 2020; 12:8733-8744. PMC: 7519869. DOI: 10.2147/CMAR.S270200. View

11.

Batista Jr M, Neves R, Peres S, Yamashita A, Shida C, Farmer S . Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia. J Endocrinol. 2012; 215(3):363-73. DOI: 10.1530/JOE-12-0307. View

12.

Bebelman M, Smit M, Pegtel D, Baglio S . Biogenesis and function of extracellular vesicles in cancer. Pharmacol Ther. 2018; 188:1-11. DOI: 10.1016/j.pharmthera.2018.02.013. View

13.

Miao C, Zhang W, Feng L, Gu X, Shen Q, Lu S . Cancer-derived exosome miRNAs induce skeletal muscle wasting by Bcl-2-mediated apoptosis in colon cancer cachexia. Mol Ther Nucleic Acids. 2021; 24:923-938. PMC: 8141664. DOI: 10.1016/j.omtn.2021.04.015. View

14.

Kir S, White J, Kleiner S, Kazak L, Cohen P, Baracos V . Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Nature. 2014; 513(7516):100-4. PMC: 4224962. DOI: 10.1038/nature13528. View

15.

Peurichard D, Delebecque F, Lorsignol A, Barreau C, Rouquette J, Descombes X . Simple mechanical cues could explain adipose tissue morphology. J Theor Biol. 2017; 429:61-81. DOI: 10.1016/j.jtbi.2017.06.030. View

16.

Ruan X, Cao M, Yan W, Jones Y, Gustafsson A, Patel H . Cancer-cell-secreted extracellular vesicles target p53 to impair mitochondrial function in muscle. EMBO Rep. 2023; 24(9):e56464. PMC: 10481655. DOI: 10.15252/embr.202256464. View

17.

Wang S, Xu M, Xiao X, Wang L, Sun Z, Guan M . Pancreatic cancer cell exosomes induce lipidomics changes in adipocytes. Adipocyte. 2022; 11(1):346-355. PMC: 9235897. DOI: 10.1080/21623945.2022.2084900. View

18.

Kir S, Spiegelman B . CACHEXIA & BROWN FAT: A BURNING ISSUE IN CANCER. Trends Cancer. 2017; 2(9):461-463. PMC: 5407404. DOI: 10.1016/j.trecan.2016.07.005. View

19.

Hu Y, Liu L, Chen Y, Zhang X, Zhou H, Hu S . Cancer-cell-secreted miR-204-5p induces leptin signalling pathway in white adipose tissue to promote cancer-associated cachexia. Nat Commun. 2023; 14(1):5179. PMC: 10449837. DOI: 10.1038/s41467-023-40571-9. View

20.

He W, Calore F, Londhe P, Canella A, Guttridge D, Croce C . Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci U S A. 2014; 111(12):4525-9. PMC: 3970508. DOI: 10.1073/pnas.1402714111. View